Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Healthcare Cannabis
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Core One Labs Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Stranius75on Jun 01, 2018 1:22pm
32 Views
Post# 28112215

RE:RE:RE:RE:RE:Research report Revised - Couple Spelling Errors Thankyou.

RE:RE:RE:RE:RE:Research report Revised - Couple Spelling Errors Thankyou.Any monkey and will and is making oil. That’s why whatever temporary LOI that they maybe will be extracting fir is just that ... TEMPORARY until they have the Super Critical CO3 extraction up and running then LDS again has nothing ....
Evolu7ion wrote: Precisely why LDS would be such an extremely attractive Partnership/Acquisition target for ACB/Aurora/Canopy etc. It has the oil/distilate process down as well as Cali licenses, one of these corps will have an abundence of crop supply. Wouldn't be surprised to see a deal struck at round $4-5 per share.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities